Can you smell that? Whoa! It smells like a rotten, spoiled, foul attitude. My attitude has been FOUL this week.

This cave entrance is open from the get-go and in the same spot as its Light World counterpart. It contains a Great Fairy that will refill your health meter.

Just south of Winnipeg, the snow maze near St. Adolphe holds the title ... Did you know that the Manitoba government has implemented free entry to all provincial parks during the month of February?

After making a trip through the operating room in Poppy Playtime Chapter 4, the Doctor pulls one final move on players, trapping them in an underground cage maze. The cages are filled with violent ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

Metsera and Maze Therapeutics are the second and third biotechnology firms this year to go public, raising $275 million and $140 million, respectively, in a pair of new stock offerings priced Thursday ...

Jennifer, I want to start with you on CBP-1. That's the Biden era phone app that allowed migrants to schedule an appointment at a legal border entry point to be processed by American immigration ...

An unveiling ceremony has taken place to welcome an ox sculpture to its permanent home on the roof terrace of the Westgate in Oxford. The Looking for Alice sculpture was part of the OxTrail art ...

Discovering one and exploring it will transport players to even more worlds influenced by sci-fi and fantasy fiction, with some of the levels including outer space, an Alice in Wonderland-themed ...

Maze Ther­a­peu­tics is eye­ing a $113 mil­lion ini­tial pub­lic of­fer­ing a lit­tle un­der two months af­ter re­veal­ing a $115 mil­lion Se­ries D.

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...